{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:26:45Z","timestamp":1792801605543,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U20A20362"],"award-info":[{"award-number":["U20A20362"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92369103"],"award-info":[{"award-number":["92369103"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06162-6","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:38:02Z","timestamp":1740119882000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Function and structure of broadly neutralizing antibodies against SARS-CoV-2 Omicron variants isolated from prototype strain infected convalescents"],"prefix":"10.1186","volume":"23","author":[{"given":"Dan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiqin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwei","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqi","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changzhong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxian","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8020-9768","authenticated-orcid":false,"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"key":"6162_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.reprotox.2022.10.003","volume":"114","author":"SN Piekos","year":"2022","unstructured":"Piekos SN, Price ND, Hood L, Hadlock JJ. The impact of maternal SARS-CoV-2 infection and COVID-19 vaccination on maternal-fetal outcomes. Reprod Toxicol. 2022;114:33\u201343.","journal-title":"Reprod Toxicol"},{"key":"6162_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11226645","author":"T Ntounis","year":"2022","unstructured":"Ntounis T, Prokopakis I, Koutras A, Fasoulakis Z, Pittokopitou S, Valsamaki A, Chionis A, Kontogeorgi E, Lampraki V, Peraki A, et al. Pregnancy and COVID-19. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11226645.","journal-title":"J Clin Med"},{"key":"6162_CR3","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.chom.2022.03.029","volume":"30","author":"SI Richardson","year":"2022","unstructured":"Richardson SI, Madzorera VS, Spencer H, Manamela NP, van der Mescht MA, Lambson BE, Oosthuysen B, Ayres F, Makhado Z, Moyo-Gwete T, et al. SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individuals. Cell Host Microbe. 2022;30:880\u20136.","journal-title":"Cell Host Microbe"},{"key":"6162_CR4","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01244-21","author":"OS Adeniji","year":"2021","unstructured":"Adeniji OS, Giron LB, Purwar M, Zilberstein NF, Kulkarni AJ, Shaikh MW, Balk RA, Moy JN, Forsyth CB, Liu Q, et al. COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions. mBio. 2021. https:\/\/doi.org\/10.1128\/mBio.01244-21.","journal-title":"mBio"},{"key":"6162_CR5","first-page":"205","volume":"3","author":"L Yang","year":"2020","unstructured":"Yang L, Liu W, Yu X, Wu M, Reichert JM, Ho M. COVID-19 antibody therapeutics tracker: a global online database of antibody therapeutics for the prevention and treatment of COVID-19. Antib Ther. 2020;3:205\u201312.","journal-title":"Antib Ther"},{"key":"6162_CR6","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.ijbiomac.2021.07.013","volume":"186","author":"PK Baral","year":"2021","unstructured":"Baral PK, Yin J, James M. Treatment and prevention strategies for the COVID 19 pandemic: a review of immunotherapeutic approaches for neutralizing SARS-CoV-2. Int J Biol Macromol. 2021;186:490\u2013500.","journal-title":"Int J Biol Macromol"},{"key":"6162_CR7","first-page":"521","volume":"614","author":"Y Cao","year":"2023","unstructured":"Cao Y, Jian F, Wang J, Yu Y, Song W, Yisimayi A, Wang J, An R, Chen X, Zhang N, et al. Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution. Nature. 2023;614:521\u20139.","journal-title":"Nature"},{"key":"6162_CR8","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2024.29.2.2300740","author":"LM Jeworowski","year":"2024","unstructured":"Jeworowski LM, Muhlemann B, Walper F, Schmidt ML, Jansen J, Krumbholz A, Simon-Loriere E, Jones TC, Corman VM, Drosten C. Humoral immune escape by current SARS-CoV-2 variants BA.2.86 and JN.1, December 2023. Euro Surveill. 2024. https:\/\/doi.org\/10.2807\/1560-7917.ES.2024.29.2.2300740.","journal-title":"Euro Surveill"},{"key":"6162_CR9","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1038\/s41467-024-46490-7","volume":"15","author":"D Planas","year":"2024","unstructured":"Planas D, Staropoli I, Michel V, Lemoine F, Donati F, Prot M, Porrot F, Guivel-Benhassine F, Jeyarajah B, Brisebarre A, et al. Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86 lineages combining increased fitness and antibody evasion. Nature Communication. 2024;15:2254.","journal-title":"Nature Communication"},{"key":"6162_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41577-022-00784-3","volume":"23","author":"Y Chen","year":"2023","unstructured":"Chen Y, Zhao X, Zhou H, Zhu H, Jiang S, Wang P. Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses. Nat Rev Immunol. 2023;23:189\u201399.","journal-title":"Nat Rev Immunol"},{"key":"6162_CR11","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41586-020-2852-1","volume":"588","author":"CO Barnes","year":"2020","unstructured":"Barnes CO, Jette CA, Abernathy ME, Dam KA, Esswein SR, Gristick HB, Malyutin AG, Sharaf NG, Huey-Tubman KE, Lee YE, et al. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature. 2020;588:682\u20137.","journal-title":"Nature"},{"key":"6162_CR12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41586-020-2381-y","volume":"584","author":"R Shi","year":"2020","unstructured":"Shi R, Shan C, Duan X, Chen Z, Liu P, Song J, Song T, Bi X, Han C, Wu L, et al. A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature. 2020;584:120\u20134.","journal-title":"Nature"},{"key":"6162_CR13","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41467-020-20602-5","volume":"12","author":"C Kim","year":"2021","unstructured":"Kim C, Ryu DK, Lee J, Kim YI, Seo JM, Kim YG, Jeong JH, Kim M, Kim JI, Kim P, et al. A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein. Nat Commun. 2021;12:288.","journal-title":"Nat Commun"},{"key":"6162_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf1906","author":"BE Jones","year":"2021","unstructured":"Jones BE, Brown-Augsburger PL, Corbett KS, Westendorf K, Davies J, Cujec TP, Wiethoff CM, Blackbourne JL, Heinz BA, Foster D, et al. The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates. Sci Transl Med. 2021. https:\/\/doi.org\/10.1126\/scitranslmed.abf1906.","journal-title":"Sci Transl Med"},{"key":"6162_CR15","doi-asserted-by":"publisher","first-page":"eadd5446","DOI":"10.1126\/sciimmunol.add5446","volume":"7","author":"S Luo","year":"2022","unstructured":"Luo S, Zhang J, Kreutzberger A, Eaton A, Edwards RJ, Jing C, Dai HQ, Sempowski GD, Cronin K, Parks R, et al. An antibody from single human V(H)-rearranging mouse neutralizes all SARS-CoV-2 variants through BA5 by inhibiting membrane fusion. Sci Immunol. 2022;7:eadd5446.","journal-title":"Sci Immunol"},{"key":"6162_CR16","doi-asserted-by":"publisher","first-page":"eabn8897","DOI":"10.1126\/science.abn8897","volume":"376","author":"T Zhou","year":"2022","unstructured":"Zhou T, Wang L, Misasi J, Pegu A, Zhang Y, Harris DR, Olia AS, Talana CA, Yang ES, Chen M, et al. Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529. Science. 2022;376:eabn8897.","journal-title":"Science"},{"key":"6162_CR17","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1126\/science.abb7269","volume":"368","author":"M Yuan","year":"2020","unstructured":"Yuan M, Wu NC, Zhu X, Lee CD, So R, Lv H, Mok C, Wilson IA. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. Science. 2020;368:630\u20133.","journal-title":"Science"},{"key":"6162_CR18","doi-asserted-by":"publisher","first-page":"1160283","DOI":"10.3389\/fimmu.2023.1160283","volume":"14","author":"Z Wang","year":"2023","unstructured":"Wang Z, Li D, Chen Y, Sun Y, Jin C, Hu C, Feng Y, Su J, Ren L, Hao Y, et al. Characterization of RBD-specific cross-neutralizing antibodies responses against SARS-CoV-2 variants from COVID-19 convalescents. Front Immunol. 2023;14:1160283.","journal-title":"Front Immunol"},{"key":"6162_CR19","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1038\/s41596-020-0394-5","volume":"15","author":"J Nie","year":"2020","unstructured":"Nie J, Li Q, Wu J, Zhao C, Hao H, Liu H, Zhang L, Nie L, Qin H, Wang M, et al. Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay. Nat Protoc. 2020;15:3699\u2013715.","journal-title":"Nat Protoc"},{"key":"6162_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.molimm.2022.12.011","volume":"154","author":"Y Hu","year":"2023","unstructured":"Hu Y, Li D, Yuan Z, Feng Y, Ren L, Hao Y, Wang S, Hu X, Liu Y, Hong K, et al. Characterization of a VRC01-like antibody lineage with immature VL from an HIV-1 infected Chinese donor. Mol Immunol. 2023;154:11\u201323.","journal-title":"Mol Immunol"},{"key":"6162_CR21","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.cell.2020.09.035","volume":"183","author":"S Du","year":"2020","unstructured":"Du S, Cao Y, Zhu Q, Yu P, Qi F, Wang G, Du X, Bao L, Deng W, Zhu H, et al. Structurally resolved SARS-CoV-2 antibody shows high efficacy in severely infected hamsters and provides a potent cocktail pairing strategy. Cell. 2020;183:1013\u201323.","journal-title":"Cell"},{"key":"6162_CR22","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani A, Rubinstein JL, Fleet DJ, Brubaker MA. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat Methods. 2017;14:290\u20136.","journal-title":"Nat Methods"},{"key":"6162_CR23","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/s41422-021-00555-0","volume":"31","author":"S Du","year":"2021","unstructured":"Du S, Liu P, Zhang Z, Xiao T, Yasimayi A, Huang W, Wang Y, Cao Y, Xie XS, Xiao J. Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants. Cell Res. 2021;31:1130\u20133.","journal-title":"Cell Res"},{"key":"6162_CR24","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr D Biol Crystallogr. 2010;66:486\u2013501.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"6162_CR25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen EF, Goddard TD, Huang CC, Meng EC, Couch GS, Croll TI, Morris JH, Ferrin TE. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci. 2021;30:70\u201382.","journal-title":"Protein Sci"},{"key":"6162_CR26","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41586-020-2380-z","volume":"584","author":"B Ju","year":"2020","unstructured":"Ju B, Zhang Q, Ge J, Wang R, Sun J, Ge X, Yu J, Shan S, Zhou B, Song S, et al. Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature. 2020;584:115\u20139.","journal-title":"Nature"},{"key":"6162_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cell.2020.05.025","volume":"182","author":"Y Cao","year":"2020","unstructured":"Cao Y, Su B, Guo X, Sun W, Deng Y, Bao L, Zhu Q, Zhang X, Zheng Y, Geng C, et al. Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients\u2019 B cells. Cell. 2020;182:73\u201384.","journal-title":"Cell"},{"key":"6162_CR28","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/j.cell.2021.02.032","volume":"184","author":"W Dejnirattisai","year":"2021","unstructured":"Dejnirattisai W, Zhou D, Ginn HM, Duyvesteyn H, Supasa P, Case JB, Zhao Y, Walter TS, Mentzer AJ, Liu C, et al. The antigenic anatomy of SARS-CoV-2 receptor binding domain. Cell. 2021;184:2183\u2013200.","journal-title":"Cell"},{"key":"6162_CR29","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.cell.2021.12.046","volume":"185","author":"W Dejnirattisai","year":"2022","unstructured":"Dejnirattisai W, Huo J, Zhou D, Zahradnik J, Supasa P, Liu C, Duyvesteyn H, Ginn HM, Mentzer AJ, Tuekprakhon A, et al. SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. Cell. 2022;185:467\u201384.","journal-title":"Cell"},{"key":"6162_CR30","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1038\/s41467-023-38435-3","volume":"14","author":"T Tamura","year":"2023","unstructured":"Tamura T, Ito J, Uriu K, Zahradnik J, Kida I, Anraku Y, Nasser H, Shofa M, Oda Y, Lytras S, et al. Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants. Nat Commun. 2023;14:2800.","journal-title":"Nat Commun"},{"key":"6162_CR31","doi-asserted-by":"publisher","first-page":"1183763","DOI":"10.3389\/fmicb.2023.1183763","volume":"14","author":"S Mohandas","year":"2023","unstructured":"Mohandas S, Shete A, Kumar A, Wakchaure K, Rai V, Mote C, Dighe H, Sarkale P, Gawande P, Yemul J, et al. Comparative pathogenicity of BA.2.12, BA.5.2 and XB.B1 with the delta variant in Syrian hamsters. Front Microbiol. 2023;14:1183763.","journal-title":"Front Microbiol"},{"key":"6162_CR32","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s42003-024-06015-w","volume":"7","author":"PJ Halfmann","year":"2024","unstructured":"Halfmann PJ, Iwatsuki-Horimoto K, Kuroda M, Hirata Y, Yamayoshi S, Iida S, Uraki R, Ito M, Ueki H, Furusawa Y, et al. Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters. Commun Biol. 2024;7:331.","journal-title":"Commun Biol"},{"key":"6162_CR33","first-page":"162","volume":"21","author":"AM Carabelli","year":"2023","unstructured":"Carabelli AM, Peacock TP, Thorne LG, Harvey WT, Hughes J, Peacock SJ, Barclay WS, de Silva TI, Towers GJ, Robertson DL. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat Rev Microbiol. 2023;21:162\u201377.","journal-title":"Nat Rev Microbiol"},{"key":"6162_CR34","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","volume":"19","author":"WT Harvey","year":"2021","unstructured":"Harvey WT, Carabelli AM, Jackson B, Gupta RK, Thomson EC, Harrison EM, Ludden C, Reeve R, Rambaut A, Peacock SJ, Robertson DL. SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol. 2021;19:409\u201324.","journal-title":"Nat Rev Microbiol"},{"key":"6162_CR35","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","volume":"602","author":"Y Cao","year":"2022","unstructured":"Cao Y, Wang J, Jian F, Xiao T, Song W, Yisimayi A, Huang W, Li Q, Wang P, An R, et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature. 2022;602:657\u201363.","journal-title":"Nature"},{"key":"6162_CR36","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","volume":"608","author":"Y Cao","year":"2022","unstructured":"Cao Y, Yisimayi A, Jian F, Song W, Xiao T, Wang L, Du S, Wang J, Li Q, Chen X, et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature. 2022;608:593\u2013602.","journal-title":"Nature"},{"key":"6162_CR37","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41590-023-01449-6","volume":"24","author":"B Ju","year":"2023","unstructured":"Ju B, Zhang Q, Wang Z, Aw ZQ, Chen P, Zhou B, Wang R, Ge X, Lv Q, Cheng L, et al. Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants. Nat Immunol. 2023;24:690\u20139.","journal-title":"Nat Immunol"},{"key":"6162_CR38","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41586-022-04594-4","volume":"604","author":"S Iketani","year":"2022","unstructured":"Iketani S, Liu L, Guo Y, Liu L, Chan JF, Huang Y, Wang M, Luo Y, Yu J, Chu H, et al. Antibody evasion properties of SARS-CoV-2 Omicron sublineages. Nature. 2022;604:553\u20136.","journal-title":"Nature"},{"key":"6162_CR39","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","volume":"602","author":"D Planas","year":"2022","unstructured":"Planas D, Saunders N, Maes P, Guivel-Benhassine F, Planchais C, Buchrieser J, Bolland WH, Porrot F, Staropoli I, Lemoine F, et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature. 2022;602:671\u20135.","journal-title":"Nature"},{"key":"6162_CR40","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41586-021-04387-1","volume":"602","author":"S Cele","year":"2022","unstructured":"Cele S, Jackson L, Khoury DS, Khan K, Moyo-Gwete T, Tegally H, San JE, Cromer D, Scheepers C, Amoako DG, et al. Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization. Nature. 2022;602:654\u20136.","journal-title":"Nature"},{"key":"6162_CR41","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/s41586-021-04386-2","volume":"602","author":"E Cameroni","year":"2022","unstructured":"Cameroni E, Bowen JE, Rosen LE, Saliba C, Zepeda SK, Culap K, Pinto D, VanBlargan LA, De Marco A, di Iulio J, et al. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. Nature. 2022;602:664\u201370.","journal-title":"Nature"},{"key":"6162_CR42","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/s41586-022-05542-y","volume":"612","author":"SR Stein","year":"2022","unstructured":"Stein SR, Ramelli SC, Grazioli A, Chung JY, Singh M, Yinda CK, Winkler CW, Sun J, Dickey JM, Ylaya K, et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758\u201363.","journal-title":"Nature"},{"key":"6162_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111845","volume":"41","author":"Y Cao","year":"2022","unstructured":"Cao Y, Jian F, Zhang Z, Yisimayi A, Hao X, Bao L, Yuan F, Yu Y, Du S, Wang J, et al. Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents. Cell Rep. 2022;41: 111845.","journal-title":"Cell Rep"},{"key":"6162_CR44","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.immuni.2013.04.012","volume":"39","author":"T Zhou","year":"2013","unstructured":"Zhou T, Zhu J, Wu X, Moquin S, Zhang B, Acharya P, Georgiev IS, Altae-Tran HR, Chuang GY, Joyce MG, et al. Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies. Immunity. 2013;39:245\u201358.","journal-title":"Immunity"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06162-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06162-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06162-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:38:05Z","timestamp":1740119885000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06162-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6162"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06162-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]},"assertion":[{"value":"13 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of the first affiliated hospital, Zhejiang University School of Medicine, China(approval number:2020-IIT-433). The patients\/participants provided their written informed consent to participate in this study. Animal experiments were conducted according to the standard operating procedures approved by the National Vaccine & Serum institute (NVSI) and complied with all relevant ethical regulations regarding animal research (Ethics Number: NVSI-RCD-JSDW-SER-2023031).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agreed to publish this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"212"}}